Imagine a disease so archaic it was once the bane of 18th-century sailors—scurvy. Now, in a shocking twist, it’s making a comeback among users of modern weight-loss drugs like Ozempic. But here’s where it gets controversial: Could these popular GLP-1 medications, celebrated for their appetite-suppressing powers, be inadvertently starving users of essential nutrients? According to researchers, the very effectiveness of these drugs in curbing hunger is leading some individuals to consume dangerously low amounts of nutrient-dense foods, putting them at risk for vitamin deficiencies. And this isn’t just about scurvy—a condition caused by severe vitamin C deficiency that can lead to anemia, bleeding gums, and slow wound healing. It’s about a broader nutritional crisis affecting bone, brain, gut, and skin health, as well as muscle mass.
Take musician Robbie Williams, for instance. He revealed to The Mirror last April that he developed scurvy after using a drug similar to Ozempic. ‘I’d stopped eating and I wasn’t getting nutrients,’ he admitted. His story isn’t an isolated incident. A recent review from Australia’s University of Newcastle analyzed 41 controlled GLP-1 trials involving 50,000 participants over 17 years and found a startling oversight: only two studies even bothered to evaluate overall nutrition, and just one published the results. This raises a critical question: Are we prioritizing weight loss at the expense of holistic health?
Clare Collins, a nutrition and dietetics professor at the university, sounds the alarm: ‘Nutrition plays a critical role in health, and right now it’s largely missing from the evidence.’ She highlights case reports of deficiencies in thiamine (vitamin B1) and protein, in addition to the scurvy cases being discussed anecdotally. Her solution? Health systems need to act now—before these deficiencies become widespread. She advocates for general practitioners to routinely include dietitian referrals in chronic disease management plans for GLP-1 users. Because, as she puts it, ‘when people are eating less, the quality of what they eat matters even more.’
And this is the part most people miss: While GLP-1 drugs are undeniably effective for weight loss, their long-term impact on nutrition remains largely unexplored. Should we be celebrating these medications without addressing the potential risks? Or is it time to demand more comprehensive research and proactive healthcare measures? Let’s spark a conversation—what do you think? Are we sacrificing nutrition for the sake of shedding pounds? Share your thoughts in the comments below.
